Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H14N2O4.H2O |
Molecular Weight | 244.2444 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O
InChI
InChIKey=QTAOMKOIBXZKND-PPHPATTJSA-N
InChI=1S/C10H14N2O4.H2O/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6;/h2-4,12-14H,5,11H2,1H3,(H,15,16);1H2/t10-;/m0./s1
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C10H14N2O4 |
Molecular Weight | 226.2292 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:14:20 UTC 2023
by
admin
on
Fri Dec 15 15:14:20 UTC 2023
|
Record UNII |
MNX7R8C5VO
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66884
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
||
|
LIVERTOX |
NBK548734
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
||
|
NCI_THESAURUS |
C38149
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
||
|
NDF-RT |
N0000175755
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CORBILTA (AUTHORIZED: NERVOUS SYSTEM DISEASES)
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
STALEVO (AUTHORIZED: PARKINSON DIEASE)
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
09 (LEV/CAR)
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CORBILTA (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
LEVODOPA/CARBIDOPA/ENTACAPONE ORION (AUTHORIZED: PARKINSON DISEASE)
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
||
|
NDF-RT |
N0000175754
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
||
|
WHO-ATC |
N04BA05
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
||
|
FDA ORPHAN DRUG |
129499
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB21619
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
DTXSID50904589
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
3395
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
MNX7R8C5VO
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
D002230
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
38101
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
1095506
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
38821-49-7
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
5159
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
496
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
C47431
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
MNX7R8C5VO
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
m3068
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | Merck Index | ||
|
CARBIDOPA
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
DB00190
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
CARBIDOPA
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | Description: A white to creamy white powder; odourless or almost odourless. Solubility: Slightly soluble in water; very slightly soluble in ethanol (~750 g/l) TS; practically insoluble in ether R. Category: Antiparkinsonism drug. Storage: Carbidopa should be kept in a well-closed container, protected from light. Definition: Carbidopa contains not less than 99.0% and not more than 101.0% of C10H14N2O4, calculated with reference to the anhydrous substance. | ||
|
2019
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL1201236
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
758190
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY | |||
|
751137
Created by
admin on Fri Dec 15 15:14:20 UTC 2023 , Edited by admin on Fri Dec 15 15:14:20 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
BINDER->LIGAND |
BINDING
|
||
|
ANHYDROUS->SOLVATE | |||
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||